Glaucoma News and Research

Latest Glaucoma News and Research

Father of modern corneal science honored with the 2022 António Champalimaud Vision Award

Claes H. Dohlman, MD, PhD, whose pioneering research at Mass Eye and Ear and in the Department of Ophthalmology at Harvard Medical School (HMS) has forever changed the way conditions of the cornea are understood and treated, has been presented with the 2022 António Champalimaud Vision Award for his vast contributions to vision research.

15 Sep 2022

Exposure to blue light may accelerate aging

A new study provides insights into the novel mechanisms through which blue light exposure interferes with non-retinal cell metabolic pathways in flies.

5 Sep 2022

High-quality human clinical trials needed to determine the benefits of CBD for heart disease patients

As cannabidiol (CBD) use rises, high quality randomized clinical trials are needed to determine if anti-inflammatory benefits of CBD for heart disease seen in preclinical data will work in a real-world setting, according to research presented at ACC Latin America 2022 Together with CardioAcademic.

5 Sep 2022

Individuals with early-onset diabetes, hypertension more likely to develop primary open-angle glaucoma

The earlier individuals develop Type 2 diabetes or hypertension in life, the earlier they are likely to develop primary open-angle glaucoma (POAG), the leading cause of irreversible blindness worldwide, researchers from UT Southwestern reported in a recent study.

29 Aug 2022

Caffeine metabolite could become a valuable treatment for myopia in children

A metabolite of caffeine, known as 7-MX, may slow the progression of short-sightedness, also known as myopia, in children, suggests observational research published online in the British Journal of Ophthalmology.

23 Aug 2022

Genetic variant associated with Alzheimer's disease plays a role in protecting against glaucoma

New research led by scientists at Mass Eye and Ear and Brigham and Women's Hospital, member hospitals of Mass General Brigham, reveals the role that a genetic variant associated with Alzheimer's disease, APOE4, plays in protecting against glaucoma.

16 Aug 2022

Financial incentives from pharma companies can influence how vision care practitioners prescribe branded eyedrops

In a lookback study of prescribing patterns among thousands of American ophthalmologists and optometrists, Johns Hopkins Medicine researchers concluded that eye doctors who receive even small financial incentives from pharmaceutical companies, such as free food, sponsored travel to attend meetings or consulting fees, are up to twice as likely to prescribe the companies' brand name eyedrops for glaucoma instead of cheaper generic versions.

15 Aug 2022

Study finds high level of resilience among children and adolescents living with glaucoma

Children and adolescents living with glaucoma develop a high level of emotional and social resilience to cope with this rare, chronic eye condition, a new Flinders University study reveals.

11 Aug 2022

Study uncovers new prognostic marker for multiple sclerosis severity

It is essential to assess the severity of multiple sclerosis (MS) in order to choose appropriate therapeutic measures, but this cannot be reliably done using existing methods.

10 Aug 2022

New, non-invasive imaging method may help detect an early indicator of glaucoma

A new, non-invasive ocular imaging method may be able to detect an early indicator of glaucoma in time to prevent disease progression and vision loss, according to a new study from New York Eye and Ear Infirmary of Mount Sinai.

2 Aug 2022

Black patients have higher risk of advanced vision loss after glaucoma diagnosis compared to whites

Black patients have a dramatically higher risk of advanced vision loss after a new diagnosis of primary open angle glaucoma (POAG) when compared to white patients, according to a new study from New York Eye and Ear Infirmary of Mount Sinai (NYEE).

25 Jul 2022

The interplay of family history and genome-wide polygenic risk scores across 24 common diseases

A new study has investigated the interplay of FH and genome-wide PRS

11 Jul 2022

New resource-light model can identify many common eye diseases

Automation in disease diagnosis is reliant on deep learning models that can accurately and efficiently identify measurements of tumors, tissue volume, or other sorts of abnormalities.

24 Jun 2022

RUDN doctors propose an alternative method of surgical management of glaucoma

RUDN University doctors have proposed an alternative method of surgical management of glaucoma. The main risk factor of glaucoma is increased pressure in the eye.

22 Jun 2022

Study: Glaucoma diagnosis not associated with steeper rates of cognitive decline

Previous studies have looked for links between glaucoma-;a neurodegenerative disorder that's the leading cause of irreversible blindness-;and cognitive function, but they've generated mixed results.

22 Jun 2022

A proposal to import drugs from other countries creates an unusual alliance in the Senate

Harmony is not often found between two of the most boisterous senators on Capitol Hill, Bernie Sanders (I-Vt.) and Rand Paul (R-Ky.).

17 Jun 2022

Stem cell models help determine previously unknown genetic markers of glaucoma

Stem cell models of the retina and optical nerve have been used to identify previously unknown genetic markers of glaucoma, in research jointly led by scientists from the Garvan Institute of Medical Research, the University of Melbourne, and the Centre for Eye Research Australia.

9 Jun 2022

Glaucoma News and Research

Latest Glaucoma News and Research

Father of modern corneal science honored with the 2022 António Champalimaud Vision Award

Exposure to blue light may accelerate aging

High-quality human clinical trials needed to determine the benefits of CBD for heart disease patients

Individuals with early-onset diabetes, hypertension more likely to develop primary open-angle glaucoma

Caffeine metabolite could become a valuable treatment for myopia in children

Genetic variant associated with Alzheimer's disease plays a role in protecting against glaucoma

Financial incentives from pharma companies can influence how vision care practitioners prescribe branded eyedrops

Study finds high level of resilience among children and adolescents living with glaucoma

Study uncovers new prognostic marker for multiple sclerosis severity

New, non-invasive imaging method may help detect an early indicator of glaucoma

Black patients have higher risk of advanced vision loss after glaucoma diagnosis compared to whites

The interplay of family history and genome-wide polygenic risk scores across 24 common diseases

New resource-light model can identify many common eye diseases

RUDN doctors propose an alternative method of surgical management of glaucoma

Study: Glaucoma diagnosis not associated with steeper rates of cognitive decline

A proposal to import drugs from other countries creates an unusual alliance in the Senate

Stem cell models help determine previously unknown genetic markers of glaucoma

Detailed genetic roadmap of glaucoma will help develop new drugs to combat the disease

Topical ocular administration of progesterone could be viable treatment for retinitis pigmentosa

Glaucoma treatment using smart contact lenses that release drugs

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Glaucoma News and Research

Latest Glaucoma News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in